Imperial College London and ketamine research
Leading research on how ketamine and related compounds reshape brain activity and connectivity.
Overview
Imperial College London's Centre for Psychedelic Research is internationally recognized for neuroimaging work showing how rapid-acting compounds modulate the default mode network and large-scale brain connectivity — providing a mechanistic window into how patients experience therapeutic effects.
Key contributions
- Brain imaging studies during and after ketamine administration
- Research on default mode network changes
- Comparative neuroscience across rapid-acting compounds
- Translational work linking brain dynamics to clinical outcomes
Selected studies
Default mode network connectivity following rapid-acting antidepressants
fMRI evidence of altered network connectivity correlating with symptom improvement.
Visit the institution
Learn more directly from Imperial College London at https://www.imperial.ac.uk/psychedelic-research-centre/.
Location: London, United Kingdom. Studies listed here are representative and not exhaustive. For full literature, consult PubMed or the institution's own publications.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.